Archived News Home

Predicting the Most Effective Multiple Myeloma Drug for Patients

Aug 31, 2020
Image of Cells

Daniel Sherbenou, MD, PhD, CU Cancer Center member and Division of Hematology assistant professor answered questions on FDA-approved multiple myeloma drugs with Oncology Times. 

Read the Article

Tags: 2020 Hematology in the News research